Related Experiment Video

Updated: Feb 28, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.4K

miRNA-340 inhibits osteoclast differentiation via repression of MITF

Hongying Zhao1,2, Jun Zhang2,3, Haiyu Shao2,3

  • 1Department of Pharmacy, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.

Bioscience Reports
|June 14, 2017
PubMed

Insights

MicroRNA-340 (miR-340) suppresses osteoclast differentiation by inhibiting the microphthalmia-associated transcription factor (MITF). This finding offers potential therapeutic targets for bone-related diseases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) regulate crucial biological processes, including osteoclast differentiation.
  • Microphthalmia-associated transcription factor (MITF) is a key transcription factor in osteoclastogenesis.
  • The specific roles of miR-340 and MITF in osteoclast differentiation require further elucidation.

Purpose of the Study:

  • To investigate the role of miR-340 in osteoclast differentiation.
  • To determine the regulatory relationship between miR-340 and MITF.
  • To explore the potential of targeting miR-340 and MITF for therapeutic interventions in osteoclast-associated diseases.

Main Methods:

  • Osteoclast differentiation induced in bone marrow-derived macrophages (BMMs).
  • Quantitative reverse transcription PCR (qRT-PCR) and Western blotting to assess gene and protein expression.
  • Luciferase reporter assay to confirm direct interaction between miR-340 and MITF.
  • Gene silencing and overexpression techniques to modulate miR-340 and MITF levels.

Main Results:

  • miR-340 expression was significantly downregulated during osteoclast differentiation.
  • Overexpression of miR-340 inhibited osteoclast differentiation and reduced MITF expression at both mRNA and protein levels.
  • Silencing MITF impaired the expression of key osteoclast markers, including TRAP, calcitonin receptor, V-ATPase d2, and cathepsin K.
  • miR-340 directly targets MITF, suppressing osteoclast formation.

Conclusions:

  • miR-340 plays an inhibitory role in osteoclast differentiation by targeting MITF.
  • The miR-340/MITF axis represents a potential therapeutic strategy for managing osteoclast-related disorders.
  • Further research into this pathway could lead to novel treatments for bone diseases.
Keywords:
MITFOsteoclast differentiationmiRNA-340

More Related Videos

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.7K
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K